Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.
Richard J CassidyJeffrey M SwitchenkoEn ChengRenjian JiangJaymin JhaveriKirtesh R PatelDaniel G TanenbaumMaria C RussellConor E SteuerTheresa W GillespieMark W McDonaldJerome C LandryPublished in: Cancer (2017)
A significant portion of octogenarians and nonagenarians with stage II/III rectal adenocarcinomas do not receive treatment. African American race and living in a less educated community are associated with not receiving therapy. This series suggests that CRT+S is a reasonable strategy for elderly patients who can tolerate therapy. Cancer 2017;123:4325-36. © 2017 American Cancer Society.